Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:

NCT ID: NCT05727072 Completed - Healthy Clinical Trials

A Study of LY3848575 in Healthy Participants

Start date: February 10, 2023
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to evaluate the safety and tolerability of LY3848575 when administered either intravenously or subcutaneously in single ascending or multiple doses in healthy non-Japanese and first generation Japanese participants. The study will also assess how fast LY3848575 gets into the blood stream and how long it takes the body to remove it. The study is open to healthy participants. The study will last up to approximately 142 days excluding the screening period of 28 days.

NCT ID: NCT05725811 Completed - Healthy Clinical Trials

Immediate Effects of Myofascial Release on the Quadriceps or Hamstrings on Active Cervical Range of Motion

Start date: February 20, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to verify the immediate effects of quadriceps or hamstring myofascial release on the active cervical flexion and extension range of motion.

NCT ID: NCT05725005 Completed - Healthy Clinical Trials

PET Study of Repeated ASN51 in Healthy Volunteers

Start date: January 26, 2023
Phase: Phase 1
Study type: Interventional

This is a phase 1, open-label, dose escalation, PET study to investigate the brain occupancy of O-GlcNAcase, and the PD response in PBMCs, after repeated doses of ASN51 in healthy subjects.

NCT ID: NCT05723874 Completed - Healthy Clinical Trials

A Study in Healthy Men to Test Whether Bosentan Influences the Amount of BI 425809 in the Blood

Start date: March 6, 2023
Phase: Phase 1
Study type: Interventional

The main objective of this trial is to investigate the relative bioavailability of BI 425809 given alone (Reference) compared to a combined administration with the moderate CYP3A4 inducer bosentan (Test) following repeated oral administration.

NCT ID: NCT05723549 Completed - Healthy Clinical Trials

A Study to Evaluate the PK, Safety and Tolerability of HCP1803.

Start date: February 2, 2023
Phase: Phase 1
Study type: Interventional

A randomized, open-label, single-dose parallel study to evaluate the pharmacokinetics, safety and tolerability of HCP1803 in healthy male volunteers.

NCT ID: NCT05723510 Completed - Healthy Clinical Trials

PK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy Volunteers

Start date: March 6, 2023
Phase: Phase 1
Study type: Interventional

This study aims to evaluate the effects of combination therapy of tegoprazan and novel oral anticoagulants (NOACs) on the pharmacokinetic and pharmacodynamic properties of NOACs in healthy adults.

NCT ID: NCT05722262 Completed - Healthy Clinical Trials

Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452

Start date: February 24, 2023
Phase: Phase 1
Study type: Interventional

The goal of this clinical trial is to demonstrate the bioequivalence of single oral administration of K-001 relative to single oral co-administration of separate tablets of K-877-ER and CSG452 in healthy adult volunteers, and to characterize the food effect on the Pharmacokinetics(PK) of K-001.

NCT ID: NCT05721521 Completed - Healthy Clinical Trials

The Effects of Exercise Intensity on Mood and Wellbeing

Start date: November 3, 2022
Phase: N/A
Study type: Interventional

The study will adopt a between-within group design where participants will exercise at 1 of 4 intensities for 30 minutes at SportsPark Reading. Mood, mental health (e.g., state anxiety and immediate depressive feelings) and physiological parameters (heart rate, blood pressure and body temperature) will be assessed before and after exercise intervention to compare the acute change across time for each intensity condition (no exercise (control), low, moderate, high).

NCT ID: NCT05721131 Completed - Healthy Clinical Trials

NC Thermometer (Gen 3) ISO 80601-2-56 Validation

Start date: January 10, 2023
Phase:
Study type: Observational

The purpose of this clinical validation is to evaluate the the clinical bias, the limits of agreement, and the clinical repeatability of measuring oral temperature using a new thermometer, NC° Thermometer (Gen 3), compared to a reference clinical thermometer.

NCT ID: NCT05720520 Completed - Healthy Clinical Trials

Effect of Game-Based Phone Application on Nursing Students' Knowledge and Skills on Intestinal Stoma and Peristomal Care

Start date: November 20, 2023
Phase: N/A
Study type: Interventional

Purpose: The purpose is to determine effect of game-based virtual reality phone application on nursing students' knowledge and skills on intestinal stoma and peristomal skin care. Material and methods:This study will be conducted as a single-blind randomized controlled experimental study between March-April 2023. The students in the experimental group will play the developed mobile game on stoma and peristomal skin care as much as they want for 5 days, while the students in the control group will perform skills on stoma and peristomal skin care on the model in the skill laboratory for only one day. After performing the inteventions, the skills and knowledge measurements of the students in both groups will be measured by the researcher through the forms prepared in accordance with the literature. After four weeks, the permanence levels of the students in both groups regarding stoma and peristomal skin care will be measured and the data collection process of the study will be terminated.